AP1530A - Pharmaceutical composition for intramuscular injection containing loxoprofen. - Google Patents
Pharmaceutical composition for intramuscular injection containing loxoprofen.Info
- Publication number
- AP1530A AP1530A APAP/P/2002/002594A AP2002002594A AP1530A AP 1530 A AP1530 A AP 1530A AP 2002002594 A AP2002002594 A AP 2002002594A AP 1530 A AP1530 A AP 1530A
- Authority
- AP
- ARIPO
- Prior art keywords
- intramuscular injection
- pharmaceutical composition
- injection containing
- containing loxoprofen
- loxoprofen
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Disclosed is a formulation for intramuscular injection containing loxoprofen or a pharmaceutically acceptable salt thereof, having an excellent anti-inflammatory analgesic effect, as an active ingredient.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2000-0076298A KR100405161B1 (en) | 2000-12-14 | 2000-12-14 | Pharmaceutical composition for intramuscular injection containing loxoprofen |
PCT/KR2001/002161 WO2002047661A1 (en) | 2000-12-14 | 2001-12-13 | Pharmaceutical composition for intramuscular injection containing loxoprofen |
Publications (2)
Publication Number | Publication Date |
---|---|
AP2002002594A0 AP2002002594A0 (en) | 2002-09-30 |
AP1530A true AP1530A (en) | 2006-01-04 |
Family
ID=36691545
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
APAP/P/2002/002594A AP1530A (en) | 2000-12-14 | 2001-12-13 | Pharmaceutical composition for intramuscular injection containing loxoprofen. |
Country Status (12)
Country | Link |
---|---|
JP (1) | JP2004515526A (en) |
KR (1) | KR100405161B1 (en) |
CN (1) | CN1278672C (en) |
AP (1) | AP1530A (en) |
AR (1) | AR033596A1 (en) |
AU (1) | AU2002222750A1 (en) |
BR (1) | BR0108313A (en) |
MX (1) | MXPA02007788A (en) |
OA (1) | OA12175A (en) |
RU (1) | RU2232572C2 (en) |
UA (1) | UA76097C2 (en) |
WO (1) | WO2002047661A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040054008A1 (en) | 2002-09-13 | 2004-03-18 | Tohru Araki | Medicament for treatment of nocturia |
SI1615646T2 (en) | 2003-04-08 | 2022-11-30 | Progenics Pharmaceuticals, Inc. | Pharmaceutical formulations containing methylnaltrexone |
WO2009031577A1 (en) | 2007-09-04 | 2009-03-12 | Meiji Seika Kaisha, Ltd. | Injection, injection solution and injection kit preparation |
EP2243477A1 (en) * | 2009-04-22 | 2010-10-27 | Fresenius Kabi Deutschland GmbH | Paracetamol for parenteral application |
JP2011225514A (en) * | 2009-10-30 | 2011-11-10 | Kowa Co | Pharmaceutical composition containing loxoprofen or salt thereof |
EP2926810A1 (en) | 2014-03-31 | 2015-10-07 | Sanovel Ilac Sanayi ve Ticaret A.S. | Oral liquid pharmaceutical formulations of loxoprofen |
EP2926832A1 (en) | 2014-03-31 | 2015-10-07 | Sanovel Ilac Sanayi ve Ticaret A.S. | Pharmaceutical formulations of loxoprofen for topical use |
EP2939666A1 (en) | 2014-04-29 | 2015-11-04 | Sanovel Ilac Sanayi ve Ticaret A.S. | Pharmaceutical formulations of loxoprofen |
EA201692424A1 (en) | 2014-06-30 | 2017-04-28 | Сановель Илач Санайи Ве Тиджарет А.Ш. | COMBINATION OF LOXOPROPHENE AND AGONIST OF GAMMA-AMINOIL ACID RECEPTORS |
WO2016046189A1 (en) | 2014-09-24 | 2016-03-31 | Sanovel Ilac Sanayi Ve Ticaret A.S. | Loxoprofen and antispastic drug combinations |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4740374A (en) * | 1985-11-26 | 1988-04-26 | Nitto Electric Industrial Co., Ltd. | Anti-inflammatory analgesic adhesive preparation |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10120560A (en) * | 1996-08-26 | 1998-05-12 | Sankyo Co Ltd | Loxoprofen-containing preparation for external use |
TW577758B (en) * | 1997-10-27 | 2004-03-01 | Ssp Co Ltd | Intra-articular preparation for the treatment of arthropathy |
-
2000
- 2000-12-14 KR KR10-2000-0076298A patent/KR100405161B1/en not_active IP Right Cessation
-
2001
- 2001-12-13 JP JP2002549235A patent/JP2004515526A/en not_active Withdrawn
- 2001-12-13 MX MXPA02007788A patent/MXPA02007788A/en active IP Right Grant
- 2001-12-13 BR BR0108313-9A patent/BR0108313A/en not_active Application Discontinuation
- 2001-12-13 AP APAP/P/2002/002594A patent/AP1530A/en active
- 2001-12-13 RU RU2002121772/15A patent/RU2232572C2/en not_active IP Right Cessation
- 2001-12-13 OA OA1200200244A patent/OA12175A/en unknown
- 2001-12-13 UA UA2002086717A patent/UA76097C2/en unknown
- 2001-12-13 AU AU2002222750A patent/AU2002222750A1/en not_active Abandoned
- 2001-12-13 WO PCT/KR2001/002161 patent/WO2002047661A1/en active Application Filing
- 2001-12-13 CN CNB018049494A patent/CN1278672C/en not_active Expired - Fee Related
- 2001-12-14 AR ARP010105804A patent/AR033596A1/en unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4740374A (en) * | 1985-11-26 | 1988-04-26 | Nitto Electric Industrial Co., Ltd. | Anti-inflammatory analgesic adhesive preparation |
Non-Patent Citations (1)
Title |
---|
SUGEMOTO ET AL.: 'Inhibition of prostaglandin production in the inflammatory tissue by loxoprofen-sodium, an anti-inflammatory prodrug' BIOCHEM. PHARMCOL. vol. 42, no. 12, 1991, pages 2363 - 2368 * |
Also Published As
Publication number | Publication date |
---|---|
JP2004515526A (en) | 2004-05-27 |
AU2002222750A1 (en) | 2002-06-24 |
MXPA02007788A (en) | 2002-10-17 |
UA76097C2 (en) | 2006-07-17 |
CN1400892A (en) | 2003-03-05 |
OA12175A (en) | 2006-05-09 |
WO2002047661A1 (en) | 2002-06-20 |
AP2002002594A0 (en) | 2002-09-30 |
AR033596A1 (en) | 2003-12-26 |
CN1278672C (en) | 2006-10-11 |
RU2232572C2 (en) | 2004-07-20 |
KR100405161B1 (en) | 2003-11-12 |
BR0108313A (en) | 2003-03-11 |
KR20020046407A (en) | 2002-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2007015480A (en) | Solid dosage formulations of narcotic drugs having improved buccal adsorption. | |
AU2001260414A1 (en) | Pharmaceutical compositions for transdermal administration of anti-inflammatory agents | |
WO2002015903A3 (en) | Novel pharmaceutical composition for administering n-0923 | |
TW200503685A (en) | A pharmaceutical composition for inhibiting coronavirus | |
HUP0302319A3 (en) | Pharmaceutical composition for oral administration of active ingredient | |
MXPA04011528A (en) | Topically applicable pharmaceutical preparation. | |
WO1999055332A8 (en) | Medicinal compositions | |
BG66093B1 (en) | Controlled release compositions comprising nimesulide | |
ES2192234T3 (en) | PARENTERAL PHARMACEUTICAL COMPOSITIONS CONTAINING SALTS OF 2-ARILPROPIONIC ACIDS. | |
WO2002008217A3 (en) | COUMARIN DERIVATIVES USEFUL AS TNFα INHIBITORS | |
AU3850600A (en) | Dalda analogs and their use | |
DE60019334D1 (en) | ANTIVIRAL ARZNEI | |
ATE287264T1 (en) | ORAL MEDICINAL PRODUCTS CONTAINING BUPRENORPHINE | |
AP2003002763A0 (en) | Controlled release formulations for oral administration | |
CA2386793A1 (en) | New selective retinoid agonists | |
AP1530A (en) | Pharmaceutical composition for intramuscular injection containing loxoprofen. | |
DK1383540T3 (en) | Methods and pharmaceutical compositions for wound healing | |
SE0102440D0 (en) | New compound | |
SE9900070D0 (en) | New use | |
WO2002004012A8 (en) | Anhydrous pharmaceutical composition of vancomycin for topical use | |
CA2402707A1 (en) | Use of cdp-choline for the treatment of alcohol withdrawal syndrome | |
ECSP055804A (en) | PHARMACEUTICAL COMPOSITION | |
CA2499620A1 (en) | External preparation containing acetylsalicylic acid for inhibiting keloid formation | |
NZ521515A (en) | Composition comprising paracetamol and niflumic acid | |
ATE259802T1 (en) | COMPOUNDS WITH ANTITHROMBOTIC ACTION |